Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie L Hay

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Headache and Pain|May 22, 2026
Functional characterisation of dura mater αCGRP degradation fragments at vascular, immune, and CGRP receptor targetsMette N Jensen, Jens B Kristensen, Maria Castrillo, et al.
Biochemistry|July 23, 2019
Pharmacological Characterization and Investigation of N-Terminal Loop Amino Acids of Adrenomedullin 2 That Are Important for Receptor ActivationHala Musa, Erica R Hendrikse, Margaret A Brimble, et al.
Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.
Molecular Pharmacology|December 24, 2004
A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptorsAlex C Conner, Debbie L Hay, John Simms, et al.
Cell Discovery|July 28, 2016
Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 26, 2016
Mapping the calcitonin receptor in human brain stemRebekah L Bower, Sajedeh Eftekhari, Henry J Waldvogel, et al.
Cell Discovery|July 28, 2016
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor PharmacologyTyla I Alexander, Zoe Tasma, Andrew Siow, et al.
British Journal of Pharmacology|October 16, 2013
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activationDebbie L Hay, Paul W R Harris, Renata Kowalczyk, et al.
Cephalalgia : an International Journal of Headache|April 12, 2022
Calcitonin receptor antibody validation and expression in the rodent brainErica R Hendrikse, Tayla A Rees, Zoe Tasma, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Headache and Pain|May 22, 2026
Functional characterisation of dura mater αCGRP degradation fragments at vascular, immune, and CGRP receptor targetsMette N Jensen, Jens B Kristensen, Maria Castrillo, et al.
Biochemistry|July 23, 2019
Pharmacological Characterization and Investigation of N-Terminal Loop Amino Acids of Adrenomedullin 2 That Are Important for Receptor ActivationHala Musa, Erica R Hendrikse, Margaret A Brimble, et al.
Mayo Clinic Proceedings|January 5, 2024
Pharmacotherapies for Migraine and Translating Evidence From Bench to BedsideMessoud Ashina, Jan Hoffmann, Håkan Ashina, et al.
Molecular Pharmacology|December 24, 2004
A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptorsAlex C Conner, Debbie L Hay, John Simms, et al.
Cell Discovery|July 28, 2016
Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 26, 2016
Mapping the calcitonin receptor in human brain stemRebekah L Bower, Sajedeh Eftekhari, Henry J Waldvogel, et al.
Cell Discovery|July 28, 2016
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacologyJoseph J Gingell, John Simms, James Barwell, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor PharmacologyTyla I Alexander, Zoe Tasma, Andrew Siow, et al.
British Journal of Pharmacology|October 16, 2013
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activationDebbie L Hay, Paul W R Harris, Renata Kowalczyk, et al.
Cephalalgia : an International Journal of Headache|April 12, 2022
Calcitonin receptor antibody validation and expression in the rodent brainErica R Hendrikse, Tayla A Rees, Zoe Tasma, et al.
Pageof 15